Hormonal Regulation of Glycogen Synthesis

描述（由申请人提供）：毫无疑问，我们正处于糖尿病的全球流行之中。胰岛素抵抗被认为是该疾病的特征，其定义为不能对正常循环水平的胰岛素作出反应。这种状态的原发性病变涉及葡萄糖非氧化代谢的缺陷，表现为肌肉和肝脏中的糖原积累，也可能涉及糖原分支结构的变化。此外，糖原贮积病涉及糖原合成、降解、分支和去分支中的畸变。我们已经研究了糖原支架蛋白，其靶向参与糖原代谢的酶，并揭示了在控制糖原脱支中的作用。在目标1中，我们将研究参与糖原脱支的信号通路，重点是脱支酶AGL的调节。我们将研究激素或葡萄糖剥夺如何影响这种酶的磷酸化状态和活性。在目标2中，我们将评估糖原靶向蛋白PTG如何通过AGL影响糖原代谢。PTG可以直接与AGL相互作用，我们将探索这种相互作用的调节意义，详细评估定位和活性的控制。最后，在目标3中，我们将评估称为Laforin的双特异性蛋白磷酸酶在调节糖原代谢和分支中的作用。Laforin动态调节AGL沿着PTG。这种蛋白质由导致Lafora病的基因编码，Lafora病是一种遗传性疾病，其中无分支糖原积累，从而为正常组织中如何调节这一过程提供了重要提示。我们将寻找Laforin的其他底物，以探索这种蛋白质调节糖原合成的其他方式。总之，这些方法将允许评估糖原代谢如何在肝脏和肌肉中调节，为未来研究其在糖尿病和其他能量代谢紊乱中的潜在作用奠定基础。

DESCRIPTION (provided by applicant): There is little doubt that we are in the midst of a worldwide epidemic of diabetes. Insulin resistance is recognized as a characteristic trait of the disease, defined by the inability to respond to normal circulating levels of insulin. The primary lesion in this state involves defects in the nonoxidative metabolism of glucose, expressed as glycogen accumulation in muscle and liver, and may also involve changes in the branching structure of glycogen. Moreover, glycogen storage diseases involve aberrations in glycogen synthesis, degradation, branching and debranching. We have studied glycogen scaffolding proteins that target enzymes involved in glycogen metabolism, and uncovered a role in controlling glycogen debranching. In Aim 1, we will study the signaling pathways involved in glycogen debranching, focusing on the regulation of the debranching enzyme AGL. We will investigate how hormones or glucose deprivation might influence the phosphorylation state and activity of this enzyme. In Aim 2, we will evaluate how the glycogen targeting protein PTG influences glycogen metabolism via AGL. PTG can interact directly with AGL, and we will explore the regulatory significance of this interaction, evaluating the control of localization and activity in detail. Finally, in Aim 3, we will evaluate the role of a dual specificity protein phosphatase called Laforin in regulating glycogen metabolism and branching. Laforin dynamically regulates AGL along with PTG. The protein is encoded by the gene that causes Lafora's disease, a genetic disease in which unbranched glycogen accumulates, thus providing important hints into how this process is regulated in normal tissues. We will search for additional substrates of Laforin to explore other ways in which this protein regulates glycogen synthesis. Together, these approaches will allow for the evaluation of how glycogen metabolism is regulated in liver and muscle, setting the stage for future investigations into its potential role in the development of diabetes and other disorders of energy metabolism.